Home › Funds › Divisadero Street Capital Management, LP › CDNA
Divisadero Street Capital Management, LP position in CDNA
CAREDX INC · Health Care
Divisadero Street Capital Management, LP reported holding 1,420,205 shares of CDNA (CAREDX INC) in its Q3 2026 13F filing — a position valued at US$92.3M, representing 1.86% of its reported portfolio and ranking #15 among its reported holdings. Divisadero Street Capital Management, LP has disclosed CDNA holdings in 6 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Divisadero Street Capital Management, LP's CDNA position evolved
Divisadero Street Capital Management, LP first disclosed a stake in CDNA in Q4 2024 at 711,761 shares (US$15.2M). The position peaked in Q3 2026 at 1,420,205 shares, worth US$92.3M. Across 6 filings, Divisadero Street Capital Management, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,420,205 shares valued at US$92.3M — an increase of 719,267 shares quarter over quarter.. Notable position changes include a 34% trim in Q1 2025 (shares rose 10% over the following quarter), a 97% trim in Q2 2025 (shares fell 26% over the following quarter), a 103% increase in Q3 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 711.76K | $15.24M | New |
| Q1 2025 | 466.94K | $8.29M | Reduce |
| Q2 2025 | 12.50K | $244.25K | Reduce |
| Q3 2025 | 12.50K | $181.75K | Hold |
| Q2 2026 | 700.94K | $19.98M | New |
| Q3 2026 | 1.42M | $92.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDNA and 13F data
CDNA (CAREDX INC) is a Health Care company. 51 other funds we track also report a position in CDNA — the largest reported positions include Blue Water Life Science Advisors, LP (US$113.1M), ARK Invest (US$104.6M), GAGNON SECURITIES LLC (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDNA
- Blue Water Life Science Advisors, LP 1.74M sh · $113.10M · Q3 2026
- ARK Invest 1.61M sh · $104.59M · Q3 2026
- GAGNON SECURITIES LLC 1.07M sh · $69.84M · Q3 2026
- ORBIMED ADVISORS LLC 934.80K sh · $60.76M · Q3 2026
- Amova Asset Management Americas, Inc. 625.42K sh · $40.63M · Q3 2026
- Ophir Asset Management Pty Ltd 582.41K sh · $37.86M · Q3 2026
- Palo Alto Investors LP 424.60K sh · $27.60M · Q3 2026
- Portolan Capital Management, LLC 420.21K sh · $27.31M · Q3 2026
- Zweig-DiMenna Associates LLC 389.81K sh · $25.34M · Q3 2026
- Gagnon Advisors, LLC 286.89K sh · $18.65M · Q3 2026
More on Divisadero Street Capital Management, LP
FAQ
How long has Divisadero Street Capital Management, LP held CDNA?
Divisadero Street Capital Management, LP has disclosed CDNA holdings in 6 of the last 8 reported quarters, going back to Q4 2024.
What is Divisadero Street Capital Management, LP's current position in CDNA?
As of Q3 2026, Divisadero Street Capital Management, LP holds 1.42M shares of CDNA (CAREDX INC), valued at $92.31M, representing 1.86% of its reported portfolio and ranking #15.
Has Divisadero Street Capital Management, LP been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Divisadero Street Capital Management, LP increased its position in CDNA. The position peaked in Q3 2026 at 1.42M shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include Blue Water Life Science Advisors, LP, ARK Invest, GAGNON SECURITIES LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.